IDH1 and central nervous system cancer: An important molecular diagnosis marker is the genetic mutation in either isocitrate dehydrogenase 1 (IDH1) or isocitrate dehydrogenase 2 (IDH2), which is common in grade 2 and 3 gliomas and defining astrocytoma and oligodendroglioma [1,2].